Xeris Biopharma Holdings, Inc. ($XERS)
Filing Information
| Accession Number | 0001553595-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
209,509
Total Value
$326,254.43
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 5, 2026 | Sale | 24,907 | $7.08 | $176,256.88 | 2,705,346 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 64,265 | $1.55 | $99,610.75 | 2,769,611 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 25,136 | $1.55 | $38,960.80 | 2,794,747 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 2,900 | $3.94 | $11,426.00 | 2,797,647 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 5, 2026 | Exercise/Conversion | 64,265 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 5, 2026 | Exercise/Conversion | 25,136 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 5, 2026 | Exercise/Conversion | 2,900 | $0.00 | $0.00 | 97,100 | Direct | โ | View Details |